Compare American Superconductor Corporation (AMSC) vs Danaher Corporation (DHR) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
American Superconductor Corporation vs Danaher Corporation — how do they compare? American Superconductor Corporation trades at $32.5 (market cap $1.50B), while Danaher Corporation trades at $206.12 (market cap $147.18B). The key difference: Danaher Corporation is far larger — about 98.1× American Superconductor Corporation's market cap, and Danaher Corporation pays a 0.76% dividend while American Superconductor Corporation pays none. Which is the better fit depends on your goals.
| AMSC | DHR | |
|---|---|---|
Market Cap | $1.50B | $147.18B |
Sector | Technology | Health |
52-Week High | $66.68 | $242.05 |
52-Week Low | $25.95 | $161.91 |
Enterprise Value | $1.36B | $169.39B |
Dividend Yield | — | 0.76% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
AMSC trades at $32.77, down 0.41% with bearish technical signals including RSI overbought conditions and negative cash flow trends. The company reported strong revenue growth of 30% year-over-year in Q1 2026 to $94.1 million but faces margin pressure, with earnings missing estimates. Record orders above $130 million and a $400 million backlog provide visibility, though valuation metrics show mixed signals with a reasonable P/E of 10.06 but elevated EV/EBITDA of 63.13.
Outlook remains cautiously optimistic given strong order pipeline and exposure to energy infrastructure growth, particularly in grid solutions and data center markets. Key risks include margin compression from cost pressures and execution challenges in integrating recent growth. Analyst consensus leans bullish with 53% buy ratings, but investors should monitor Q3 earnings delivery and cash flow improvement for sustained upside.
Danaher (DHR) trades at $207.44, up 1.31% today, near its pivot point of $207. The stock exhibits a bullish technical trend, supported by moving averages, though RSI levels suggest overbought conditions. Fundamentally, the company maintains strong profitability with a 58.51% gross margin and has beaten EPS estimates for three consecutive quarters. Recent news highlights the acquisition of Masimo and new product launches from its SCIEX unit, signaling growth initiatives.
The outlook remains positive with analyst consensus favoring a Buy rating and a $202.33 price target, though the current price exceeds this. Risks include a high P/E ratio of 37.32 and ongoing legal settlements, but robust cash flow and institutional accumulation provide support. Earnings growth in the biotechnology segment is a key catalyst for further upside.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About American Superconductor Corporation
AMSC provides energy technology solutions for smarter and cleaner power grids. It offers wind turbine electronic controls and advanced grid systems that enhance the reliability and efficiency of renewable energy networks.
Read more on AMSC →About Danaher Corporation
In 1984, Danaher's founders transformed a real estate organization into an industrial-focused manufacturing company. Through a series of mergers, acquisitions, and divestitures, including the Fortive separation in 2016, Danaher now focuses primarily on manufacturing scientific instruments and consumables in three segments: life sciences, diagnostics, and environmental and applied solutions. In late 2019, Danaher separated from its dental business through an initial public offering process, and in early 2020, it acquired GE's Biopharma business, now called Cytiva, which added to its life sciences segment.
Read more on DHR →
